Improving the Outcomes of Community-based Management of Acute Malnutrition

Status Completed

Clinical Trial Summary

Severe acute malnutrition (SAM) affects 16 million children at any one time and is responsible for the deaths of over 500,000 children under 5 years of age each year. Treatment for severe acute malnutrition is based on the Community-based Management of Acute Malnutrition (CMAM) model. The current methods used for detecting high risk children have not prevented 5% mortality observed in regions using this program. The purpose of the study is to provide evidence that objective methods for detecting high risk children can be used to optimize efficiency of Community-based Management of Acute Malnutrition (CMAM) treatment programs and thus improve child health outcomes.

Clinical Trial Description

A prospective observational study in inpatient care within community-based management of acute malnutrition(CMAM) program run by the nongovernmental organization called Alliance for International Medical Action (ALIMA) within the University of Maiduguri Teaching Hospital, Maiduguri, Nigeria The objectives of the study are to validate the BedsidePEWS scores as a measure of severity of illness in children who are treated as inpatients for severe acute malnutrition and to compare the BedsidePEWS scores with other risk factors associated for mortality and relapse of children with severe acute malnutrition. The design is a prospective observational study of 1000 children admitted as inpatients in a CMAM program in Maidaguri Teaching Hospital in Maidaguri, Nigeria. Data collection (estimated duration 4-5 months) involves vital signs, and risk factor assessment every 12 hours for duration of hospitalization. Blood test for hemoglobin and malaria will be done once upon admission. Outcomes will be measured every 12 hours and include mortality and/or escalation and de-escalation of care. Logistic regression with significance testing will be used to compare BedsidePEWS scores and risk factors between patients and among individual patients within the outcome categories. Exploratory sensitivity analyses will repeat the main logistic regression analyses to evaluate the performance of partial BedsidePEWS score in patients with missing data of 1-3 of the 7 components, by randomly removing 1-3 data elements from the score calculation from patients, and by removing systolic blood pressure from scoring. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04582773
Study type	Observational
Source	The Hospital for Sick Children
Contact
Status	Completed
Phase
Start date	July 22, 2019
Completion date	October 30, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03360877` - Prevention of Nosocomial Infections (CleanKids)	N/A
Completed	`NCT04715204` - Gastrointestinal Tolerance of Under-five Children With Severe Acute Malnutrition to ONS Compared to F-75/F-100	N/A
Not yet recruiting	`NCT06038071` - Family Mid-Upper Arm Circumference (MUAC) Follow-up After Recovery From Acute Malnutrition (MODAM-fMUAC)	N/A
Not yet recruiting	`NCT06061484` - Modified Dosage for Severe Acute Malnutrition	N/A
Completed	`NCT03666572` - Pilot of a Prebiotic and Probiotic Trial in Young Infants With Severe Acute Malnutrition	Phase 2
Completed	`NCT05020847` - Effectiveness of Alternative Diets During the Stabilization Phase on Children With Complicated SAM	N/A
Completed	`NCT05015257` - Effectiveness of Four Transition Dietary Regimens in the Hospital Management of Children With Kwashiorkor.	N/A
Recruiting	`NCT06123390` - Evaluating RISQ System Implementation in Acutely Malnourished Children in Chad (CRIMSON)	N/A
Completed	`NCT03370003` - Non-routine Use of Antibiotics (Amoxi-light)
Completed	`NCT03303131` - SAM: Discharge Based on the Use of a MUAC-based Criterion to	N/A
Recruiting	`NCT06002438` - Eggs for Gut Health	N/A
Terminated	`NCT05473234` - Azithromycin for Severe Acute Malnutrition in CMAM, Nigeria	Phase 3
Completed	`NCT01613547` - The Effect of Routine Antibiotic Use in the Outpatient Treatment of Severely Malnourished Children Without Complications	N/A
Completed	`NCT01331044` - Ready to Use Therapeutic Food (RUTF) in Severe Malnourished Children	N/A
Completed	`NCT03094247` - Feeding Malnourished Children Different Types of Fatty Acids to Promote Neurocognitive Development	N/A
Recruiting	`NCT04240990` - Development of a Diagnostic Prediction Score for Tuberculosis in Hospitalized Children With Severe Acute Malnutrition	N/A
Completed	`NCT01958905` - Efficacy and Bio-availability of Artemether-Lumefantrine in Severely Malnourished Children	N/A
Completed	`NCT05737472` - High-protein Quantity and Quality RUTF in Improving Linear Growth Among Children With Severe Wasting	N/A
Completed	`NCT03716115` - Therapeutic Approaches to Malnutrition Enteropathy	Phase 2
Completed	`NCT01593969` - A Trial of n-3 PUFA-Enriched Ready to Use Therapeutic Food for Childhood Severe Malnutrition	Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.